Valve-in-valve: the journey starts with the first prosthesis - EuroPCR 2022

The right valve choice for TAVI patient longevity and durability - EuroPCR 2022Подробнее

DurAVR THV: a valve designed for life - EuroPCR 2022Подробнее

Double jeopardy: coronary disease in patients undergoing TAVI - EuroPCR 2022Подробнее

TAVI for AR - Addressing an unmet need with the JenaValve Trilogy heart valve system - EuroPCR 2022Подробнее

Learnings from an optimised TAVI patient's journey - EuroPCR 2022Подробнее

Highlife TSMVR - (Not) only for the happy few? - EuroPCR 2022Подробнее

JenaValve Trilogy for treatment of aortic regurgitation: worldwide first results - #EuroPCR 2022Подробнее

A new focus on mitral and tricuspid valve disease - EuroPCR 2022Подробнее

The role of coronary interventionalist in TAVI - From referral to timing of PCI - EuroPCR 2022Подробнее

Transcatheter mitral valve replacement and repair: why do we need both - EuroPCR 2021Подробнее

Mitral replacement: expanding patient options, even mitral annular calcification! - EuroPCR 2022Подробнее

State-of-the-art imaging for structural heart disease interventions - EuroPCR 2022Подробнее

First dedicated transcatheter leaflet splitting device from bench to first-in-man (ShortCut)Подробнее

Planning for a long run: life-time management of bioprosthetic valve implantation - EuroPCR 2021Подробнее

Tendyne transcatheter mitral valve implantation - EuroPCR 2019Подробнее

Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR™)Подробнее

New, novel Navitor™ TAVI valve with active paravalvular leak-sealing technology - EuroPCR 2021Подробнее

PCR Tokyo Valves 2022 is approaching with 6 live webinars!Подробнее

A patient-focused transcatheter portfolio of options to treat tricuspid regurgitation - EuroPCR 2022Подробнее